DGAP-News: Leading Surgeons Highlight Nitinol Compression Anastomosis at the 130th German Congress for Surgery (DGCH)
(firmenpresse) - novoGI Inc.
13.05.2013 11:01
---------------------------------------------------------------------------
Regional Experience Substantiates Positive Global Data for novoGI(TM) ColonRing
ATLANTA, 2013-05-13 11:01 CEST (GLOBE NEWSWIRE) --
novoGI Inc. today announced the success of a scientific symposium on novoGI's
nitinol compression anastomosis in Munich at the 130th Kongress der Deutschen
Gesellschaft fur Chirurgie (DGCH), The German Congress for Surgery. DGCH is the
largest German surgical meeting, with over 8000 participants mainly from
Germany, Switzerland, and Austria and other regions.
At DGCH, the Satellite Symposium Die Anastomose bei der Tiefen Anterioren
Resektion mit dem ColonRing [Anastomoses in Low Anterior Resection with
ColonRing] included podium presentations by leading surgeons. The session
focused on clinical experience in surgical practice as well as published data
covering successful outcomes for novoGI(tm) ColonRing in terms of low leak rates
of and healing processes for low anterior resection (LAR) procedures.
Clinical presentations included:
-- Common Types of Anastomosis on the Colon and the ColonRing as a New
Alternative (ID: 2102) presented by Prof Paul-Antoine Lehur, MD (CHU de
Nantes, Nantes, France).
-- Kompressionsanastomose mit ColonRing Was Sagen die Daten? [Compression
Anastomosis with ColonRing What Does the Data Say?] (ID 2103) presented by
Prof Oliver Schwandner, MD (KH by Barmherzige Bruder, Regensburg, Germany).
-- Low Anterior Resection Anastomosis (LARA) - Personal Experience and
Management of Complications (ID 2104) presented by Prof Friedrich Herbst,
MD, FRCS, (KH Barmherzige Bruder, Vienna, Austria) who has performed over
200 compression anastomosis procedures.
The presentations were followed by panel discussion moderated by Asad Kutup, MD
on behalf of Prof Jakob R. Izbicki, FACS, FRCS, Ed. Hon. (University of
Hamburg, Hamburg, Germany).
'The depth of presentations and level of interest in compression anastomosis
with the novoGI(tm) ColonRing device at scientific meetings worldwide in recent
weeks - at the American Society of Colon&Rectal Surgeons (ASCRS) Annual
Meeting in the USA, DGCH in Germany, and major congresses in France -
underscore the importance and growing global acceptance of our clinically
proven technology for improving patient care,' noted Gavriel D. Meron, novoGI
President and Chief Executive Officer. 'The increased involvement of leading
surgeons worldwide demonstrated at the 2nd Annual Meeting of the World Congress
of Compression Anastomosis (WCCA) held recently in Phoenix, Arizona is
continuing to drive educational and research activities in this field.'
About novoGI
novoGI is focused on providing an expanding range of solutions for GI disease
management through a globally branded, high quality, market driven company. The
US headquarters are in Atlanta, Georgia; research, development and
manufacturing facilities in Netanya, Israel; and its European headquarters are
near Paris, France. The company's website is www.novoGI.com.
NOVOGI, the NOVOGI logo, the GI logo, and DEFINING THE FUTURE are trademarks
and/or registered trademarks of novoGI Inc.
CONTACT: marcom(at)novoGI.com
www.novoGI.com
News Source: NASDAQ OMX
13.05.2013 Dissemination of a Corporate News, transmitted by DGAP -
a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: novoGI Inc.
Israel
Phone:
Fax:
E-mail:
Internet:
ISIN: US9902064198
WKN:
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 13.05.2013 - 11:01 Uhr
Sprache: Deutsch
News-ID 258989
Anzahl Zeichen: 5835
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 357 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: Leading Surgeons Highlight Nitinol Compression Anastomosis at the 130th German Congress for Surgery (DGCH)"
steht unter der journalistisch-redaktionellen Verantwortung von
novoGI Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
